GLSI
Price
$8.15
Change
-$0.01 (-0.12%)
Updated
Nov 21 closing price
Capitalization
112.08M
One day until earnings call
Intraday BUY SELL Signals
NWBO
Price
$0.25
Change
+$0.01 (+4.17%)
Updated
Nov 21 closing price
Capitalization
382.71M
Intraday BUY SELL Signals
Interact to see
Advertisement

GLSI vs NWBO

Header iconGLSI vs NWBO Comparison
Open Charts GLSI vs NWBOBanner chart's image
Greenwich LifeSciences
Price$8.15
Change-$0.01 (-0.12%)
Volume$80.66K
Capitalization112.08M
Northwest Biotherapeutics
Price$0.25
Change+$0.01 (+4.17%)
Volume$6.33M
Capitalization382.71M
GLSI vs NWBO Comparison Chart in %
GLSI
Daily Signal:
Gain/Loss:
NWBO
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GLSI vs. NWBO commentary
Nov 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLSI is a Hold and NWBO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 23, 2025
Stock price -- (GLSI: $8.15 vs. NWBO: $0.25)
Brand notoriety: GLSI and NWBO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLSI: 102% vs. NWBO: 205%
Market capitalization -- GLSI: $112.08M vs. NWBO: $382.71M
GLSI [@Biotechnology] is valued at $112.08M. NWBO’s [@Biotechnology] market capitalization is $382.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $108.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLSI’s FA Score shows that 0 FA rating(s) are green whileNWBO’s FA Score has 0 green FA rating(s).

  • GLSI’s FA Score: 0 green, 5 red.
  • NWBO’s FA Score: 0 green, 5 red.
According to our system of comparison, NWBO is a better buy in the long-term than GLSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLSI’s TA Score shows that 5 TA indicator(s) are bullish while NWBO’s TA Score has 7 bullish TA indicator(s).

  • GLSI’s TA Score: 5 bullish, 4 bearish.
  • NWBO’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, NWBO is a better buy in the short-term than GLSI.

Price Growth

GLSI (@Biotechnology) experienced а -2.04% price change this week, while NWBO (@Biotechnology) price change was +3.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.01%. For the same industry, the average monthly price growth was -3.31%, and the average quarterly price growth was +62.87%.

Reported Earning Dates

GLSI is expected to report earnings on Nov 24, 2025.

Industries' Descriptions

@Biotechnology (-1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NWBO($383M) has a higher market cap than GLSI($112M). NWBO YTD gains are higher at: -9.591 vs. GLSI (-27.427). GLSI has higher annual earnings (EBITDA): -18.14M vs. NWBO (-72.28M). NWBO has more cash in the bank: 4.32M vs. GLSI (3.13M). NWBO has higher revenues than GLSI: NWBO (1.09M) vs GLSI (0).
GLSINWBOGLSI / NWBO
Capitalization112M383M29%
EBITDA-18.14M-72.28M25%
Gain YTD-27.427-9.591286%
P/E RatioN/AN/A-
Revenue01.09M-
Total Cash3.13M4.32M72%
Total DebtN/A69.8M-
FUNDAMENTALS RATINGS
NWBO: Fundamental Ratings
NWBO
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLSINWBO
RSI
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
78%
MACD
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 24 days ago
78%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 11 days ago
85%
Bearish Trend 7 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
86%
Aroon
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GLSI
Daily Signal:
Gain/Loss:
NWBO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYRRX56.941.55
+2.80%
Rydex Russell 2000 A
VCIGX13.330.19
+1.45%
VALIC Company I Dividend Value
IWTTX11.580.15
+1.31%
Voya Global High Dividend Low Vol PortS2
TRPSX29.290.36
+1.24%
Nuveen Large Cap Responsible Eq Prem
TWMIX14.24-0.05
-0.35%
American Century Emerging Markets Inv

GLSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLSI has been loosely correlated with CRSP. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if GLSI jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLSI
1D Price
Change %
GLSI100%
-0.12%
CRSP - GLSI
41%
Loosely correlated
+1.91%
CELC - GLSI
37%
Loosely correlated
+3.72%
CRBU - GLSI
37%
Loosely correlated
N/A
BEAM - GLSI
36%
Loosely correlated
+7.82%
MRNA - GLSI
36%
Loosely correlated
+6.08%
More

NWBO and

Correlation & Price change

A.I.dvisor tells us that NWBO and GLSI have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NWBO and GLSI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NWBO
1D Price
Change %
NWBO100%
+1.80%
GLSI - NWBO
23%
Poorly correlated
-0.12%
MBIO - NWBO
20%
Poorly correlated
+2.61%
AKBA - NWBO
20%
Poorly correlated
+0.65%
FATE - NWBO
8%
Poorly correlated
+3.00%
AGIO - NWBO
8%
Poorly correlated
+2.73%
More